How Does 10X Genomics Company Work?

10X Genomics Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

How Does 10X Genomics Revolutionize Life Science?

10X Genomics is at the forefront of biological system analysis, transforming the genomics and biotechnology landscape. Their innovative 10X Genomics technology provides researchers with unprecedented insights into complex biological processes, driving advancements in fields like oncology and immunology. But how does this cutting-edge 10X Genomics platform actually work, and what's driving its impact?

In 2024, 10X Genomics continued to innovate, launching new products aimed at enhancing single-cell analysis and spatial transcriptomics. Despite a slight revenue dip in 2024, the company's focus on consumables and expansion into biopharma suggests strong underlying demand for its 10X Genomics SWOT Analysis. Understanding the company's operations, including its single-cell analysis capabilities and its approach to next-generation sequencing, is key to appreciating its long-term potential.

The core of 10X Genomics' operations involves creating and delivering integrated solutions for high-throughput biological system analysis. These solutions include instruments, consumables, and software designed to support advanced genomic research. Their primary focus is on providing tools and technologies that enable detailed and efficient analysis of biological systems, catering to a diverse customer base.

The company's value proposition centers on providing cutting-edge tools for genomics research, particularly in single-cell and spatial biology. The 10X Genomics platform, including the Chromium system, Visium, and Xenium platforms, facilitates in-depth investigations across various scientific disciplines. These technologies empower researchers to conduct complex experiments and accelerate discoveries in fields such as cancer biology, immunology, and neuroscience.

10X Genomics serves a broad customer base, including academic research institutions, biotechnology companies, and pharmaceutical firms. These clients utilize 10X Genomics technology to advance their research, seeking innovative solutions to complex biological questions. The company's products are designed to streamline workflows and reduce costs, making advanced genomic analysis more accessible and affordable.

Operational Processes

Operational processes at 10X Genomics are comprehensive, encompassing technology development, manufacturing, supply chain management, and distribution. The single-cell sequencing workflow involves sample preparation, single-cell capture and barcode labeling, library construction, high-throughput sequencing, and bioinformatics analysis. The company invests in automating and unifying business processes across manufacturing, supply chain, procurement, and finance.

Global Supply Chain

10X Genomics operates a global supply chain, including a manufacturing facility and commercial hub in Singapore. This facility provides additional capacity for consumables and strengthens in-region sales and customer support, especially in the Asia-Pacific market. The Asia-Pacific market represented 25% of global sales in the first half of 2021, highlighting the importance of this region.

Innovation and Accessibility

Continuous innovation is a key aspect of 10X Genomics' operations, focusing on delivering advanced products that streamline workflows and reduce costs. The new Chromium products, such as GEM-X Flex and GEM-X Universal Multiplex, aim to democratize single-cell analysis. These products offer significant improvements in performance, workflow, and cost-effectiveness, enabling single-cell analysis at mega scale.

Customer Benefits

By making complex genomic analysis more accessible and affordable, 10X Genomics directly benefits its customers by accelerating research and facilitating breakthrough discoveries. The focus on cost reduction, potentially reaching one cent per cell, allows researchers to conduct more extensive studies. This approach enables researchers to delve deeper into genomics.

Key Technologies and Applications

10X Genomics offers a diverse product portfolio, including the Chromium platform for single-cell analysis and the Visium and Xenium platforms for spatial biology. These technologies are used in various applications, such as cancer research, immunology, and neuroscience. The company's technology allows for detailed analysis of gene expression and cellular interactions.

• Single-cell analysis enables researchers to study individual cells, providing insights into cellular heterogeneity and function.
• Spatial transcriptomics allows for the analysis of gene expression within the context of tissue structure.
• Genomics research is advanced through next-generation sequencing technologies.
• Cancer research benefits from the ability to analyze tumor microenvironments and identify therapeutic targets.

10X Genomics SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The revenue streams of 10X Genomics are primarily driven by sales of instruments, consumables, and services. The company leverages a multi-faceted approach to generate income, focusing on both product sales and recurring revenue models to ensure financial stability and growth. This strategy is crucial for supporting its ongoing research and development efforts in the field of genomics.

In 2024, total revenue reached $610.8 million, although it represented a 1% decrease compared to the previous year. The revenue breakdown highlights the importance of consumables, which generated a substantial portion of the income. The company's financial performance reflects its position in the genomics market and its strategies for revenue generation.

The company's monetization strategies include product sales for instruments and recurring revenue from consumables. 10X Genomics has also implemented strategic price adjustments to increase sales volume, particularly for large projects and new applications. The company is actively expanding its revenue sources by increasing its presence in the biopharma sector.

Revenue Breakdown in 2024

In 2024, the company's total revenue was $610.8 million. Instrument sales were $92.7 million, and consumables brought in $493.4 million. Services revenue was $24.6 million.

Consumables Revenue

Chromium consumables accounted for $372.3 million. Spatial consumables generated $121.1 million, showing a 104% growth.

Q1 2025 Revenue

Total revenue for Q1 2025 was $154.9 million, including a patent litigation settlement of $16.8 million. Excluding the settlement, revenue was $138.1 million, a 2% decrease from Q1 2024.

Spatial Consumables Growth

Spatial consumables revenue increased by 18% in Q1 2025. This growth was driven by Xenium consumables revenue.

Monetization Strategies

10X Genomics uses product sales for instruments and recurring revenue from consumables. Strategic price adjustments drive volume, especially for large projects.

Biopharma Sector Expansion

The company aims to increase biopharma revenue contribution from 15%-20% to approximately 50%. This expansion is supported by new applications and a dedicated commercial team.

The company's focus on expanding its presence in the biopharma sector is a key element of its long-term strategy. This expansion is supported by new applications and a dedicated commercial team. The company's approach to revenue generation is designed to capitalize on the growing demand for advanced genomics technologies. To understand the competitive landscape, consider exploring the Competitors Landscape of 10X Genomics.

Key Revenue Drivers and Strategies

10X Genomics leverages a combination of instrument sales, consumables, and services to generate revenue. Strategic price adjustments and a focus on the biopharma sector are key strategies.

• Instrument Sales: Sales of advanced instruments for 10X Genomics technology.
• Consumables: Recurring revenue from consumables used with the instruments.
• Services: Revenue from services, including support and analysis.
• Biopharma Expansion: Increasing revenue from biopharma customers.
• Price Adjustments: Strategic pricing to drive volume and market penetration.

10X Genomics PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

10X Genomics has achieved several key milestones and strategic moves that have significantly shaped its operations and financial performance. In 2024, the company launched major new products across its three main platforms: Chromium GEM-X, Visium HD, and Xenium Prime 5K assay. These launches were part of a broader strategy to expand its presence in the scientific tools market, enabling customers to use its products beyond basic research and democratizing access to single-cell analysis.

The company also undertook a major restructuring of its sales force in 2024, intended to refine its market strategy and product placement, and to better serve a growing diversity in products and customers. Operationally, 10X Genomics has focused on automating and unifying its business processes, including manufacturing, supply chain, procurement, and finance, to enhance efficiency and scalability. The establishment of its first manufacturing facility outside the U.S. in Singapore is a strategic move to build a more robust supply chain and better serve global customers.

10X Genomics maintains a competitive edge through its innovative technology leadership and comprehensive product portfolio. The company excels in single-cell and spatial genomics, leading the single-cell market with its Chromium platform. Its Visium and Xenium platforms also solidify its strong position in spatial biology. Strategic collaborations, such as the Billion Cells Project with the Chan Zuckerberg Initiative (CZI) and Ultima Genomics, further enhance its market position and innovation capabilities by generating extensive datasets for AI applications in biology. For more insights into the company's strategic direction, consider reading about the Growth Strategy of 10X Genomics.

Key Launches and Innovations

In 2024, 10X Genomics launched several new products, including Chromium GEM-X, Visium HD, and Xenium Prime 5K assay. The Chromium GEM-X Flex enables analysis of over 700 samples in a single run, offering a cost point of one cent per cell. These advancements are designed to enhance single-cell analysis and spatial transcriptomics capabilities.

• Chromium GEM-X: Revolutionizes single-cell analysis with cost-effective solutions.
• Visium HD: Enhances spatial transcriptomics with higher resolution.
• Xenium Prime 5K assay: Expands the scope of spatial biology research.
• Focus on democratizing access to 10X Genomics technology.

10X Genomics Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The company, a leader in the single-cell and spatial genomics markets, has a strong foothold with its 10X Genomics technology, particularly its Chromium platform, which is widely adopted in research facilities worldwide. Serving a prestigious clientele, including top-tier academic research institutions and pharmaceutical companies, the company's global reach extends to over 50 countries. The company aims to increase its presence in the biopharma sector, targeting a growth from 15-20% of its business to 50% over time.

Despite its strong market position, the company faces significant risks and headwinds. These include potential impacts from NIH funding cuts, intense competition from rivals like Illumina, and macroeconomic factors such as inflation and supply chain disruptions. Regulatory changes and international risks also pose potential challenges. A decrease in revenue from its Chromium solutions could significantly impact financial results.

Industry Position

The company holds a leading position in single-cell and spatial genomics. The Chromium platform is widely used in research. Academic research institutions account for 62% of its customer base, and pharmaceutical companies account for 28%.

Risks

The company faces risks from potential NIH funding cuts and competition. Macroeconomic factors like inflation and supply chain issues are also concerns. Regulatory changes and international risks present additional challenges.

Future Outlook

The company plans to invest in R&D to enhance products and develop new solutions. It anticipates lowering prices for certain products in 2025. Full-year 2025 revenue is projected to be between $610 million and $630 million.

Financials

The company expects to incur operating losses in the near term, with a net loss of $34.4 million in Q1 2025. It has cash and cash equivalents of $426.9 million as of March 31, 2025. Cost-cutting measures include reducing operating expenses by $50 million and an approximately 8% reduction in its global workforce in 2025.

Strategic Initiatives and Financial Projections

To sustain and expand revenue generation, the company is focusing on several key initiatives. These include continued investment in research and development to enhance existing products and develop new solutions. The company's product roadmap includes plate-based workflows for Chromium GEM-X Flex, enabling over 700 samples in a single run, and additions to the Visium HD platform for high-resolution spatial profiling.

• The company plans to lower prices for certain products in 2025 to increase sales volume.
• The company projects full-year 2025 revenue to be in the range of $610 million to $630 million, representing 0% to 3% growth over 2024.
• Double-digit growth is expected in both Chromium reactions and overall spatial revenue.
• The company is implementing cost-cutting measures, including reducing operating expenses by $50 million and cutting approximately 8% of its global workforce in 2025.

10X Genomics Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs